Response rates according to ACR Ped 30 after 12 weeks of treatment [clinicaltrials_resource:8de78b1c3507c0df000c4733903cfc9b]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Response rates according to ACR Ped 30 after 12 weeks of treatment [clinicaltrials_resource:8de78b1c3507c0df000c4733903cfc9b]
Bio2RDF identifier
8de78b1c3507c0df000c4733903cfc9b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8de78b1c3507c0df000c4733903cfc9b
measure [clinicaltrials_vocabulary:measure]
Response rates according to ACR Ped 30
time frame [clinicaltrials_vocabulary:time-frame]
after 12 weeks of treatment
identifier
clinicaltrials_resource:8de78b1c3507c0df000c4733903cfc9b
title
Response rates according to ACR Ped 30 after 12 weeks of treatment
@en
type
label
Response rates according to AC ...... 78b1c3507c0df000c4733903cfc9b]
@en